112 related articles for article (PubMed ID: 21498960)
1. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: novel mechanism of the expression and amplification of cell surface-associated fibrinolytic activity demonstrated by real-time imaging analysis.
Suzuki Y; Urano T
J Pharmacol Sci; 2011; 116(1):19-24. PubMed ID: 21498960
[TBL] [Abstract][Full Text] [Related]
2. TM5275 prolongs secreted tissue plasminogen activator retention and enhances fibrinolysis on vascular endothelial cells.
Yasui H; Suzuki Y; Sano H; Suda T; Chida K; Dan T; Miyata T; Urano T
Thromb Res; 2013 Jul; 132(1):100-5. PubMed ID: 23611258
[TBL] [Abstract][Full Text] [Related]
3. Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells.
Suzuki Y; Mogami H; Ihara H; Urano T
Blood; 2009 Jan; 113(2):470-8. PubMed ID: 18922856
[TBL] [Abstract][Full Text] [Related]
4. Accelerated fibrinolysis and its propagation on vascular endothelial cells by secreted and retained tPA.
Urano T; Suzuki Y
J Biomed Biotechnol; 2012; 2012():208108. PubMed ID: 23118500
[TBL] [Abstract][Full Text] [Related]
5. Plasmin-dependent modulation of the blood-brain barrier: a major consideration during tPA-induced thrombolysis?
Niego B; Medcalf RL
J Cereb Blood Flow Metab; 2014 Aug; 34(8):1283-96. PubMed ID: 24896566
[TBL] [Abstract][Full Text] [Related]
6. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes.
Lijnen HR; Van Hoef B; Lupu F; Moons L; Carmeliet P; Collen D
Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1035-45. PubMed ID: 9672063
[TBL] [Abstract][Full Text] [Related]
7. Novel situations of endothelial injury in stroke--mechanisms of stroke and strategy of drug development: intracranial bleeding associated with the treatment of ischemic stroke: thrombolytic treatment of ischemia-affected endothelial cells with tissue-type plasminogen activator.
Suzuki Y; Nagai N; Umemura K
J Pharmacol Sci; 2011; 116(1):25-9. PubMed ID: 21498957
[TBL] [Abstract][Full Text] [Related]
8. Binding of tissue plasminogen activator to human endothelial cells. Importance of the B-chain as a ligand.
Cheng XF; Bäck O; Nilsson TK; Nylander Lundqvist E; Pohl G; Wallén P
Biochem J; 1992 Oct; 287 ( Pt 2)(Pt 2):407-13. PubMed ID: 1332673
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategies.
Adibhatla RM; Hatcher JF
CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):243-53. PubMed ID: 18673209
[TBL] [Abstract][Full Text] [Related]
10. Novel distribution pattern of fibrinolytic components in rabbit tissues extract: a preliminary study.
Lu XG; Wu XG; Xu XH; Gong XB; Zhou X; Xu GB; Zhu L; Zhao XY
J Zhejiang Univ Sci B; 2007 Aug; 8(8):570-4. PubMed ID: 17657859
[TBL] [Abstract][Full Text] [Related]
11. Surface-retained tPA is essential for effective fibrinolysis on vascular endothelial cells.
Suzuki Y; Yasui H; Brzoska T; Mogami H; Urano T
Blood; 2011 Sep; 118(11):3182-5. PubMed ID: 21791417
[TBL] [Abstract][Full Text] [Related]
12. Regulation of plasminogen activation on cell surfaces and fibrin.
Urano T; Castellino FJ; Suzuki Y
J Thromb Haemost; 2018 May; 16(8):1487-97. PubMed ID: 29779246
[TBL] [Abstract][Full Text] [Related]
13. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
Lapergue B; Dang BQ; Desilles JP; Ortiz-Munoz G; Delbosc S; Loyau S; Louedec L; Couraud PO; Mazighi M; Michel JB; Meilhac O; Amarenco P
Stroke; 2013 Mar; 44(3):699-707. PubMed ID: 23422087
[TBL] [Abstract][Full Text] [Related]
14. Endogenously generated plasmin at the vascular wall injury site amplifies lysine binding site-dependent plasminogen accumulation in microthrombi.
Brzoska T; Tanaka-Murakami A; Suzuki Y; Sano H; Kanayama N; Urano T
PLoS One; 2015; 10(3):e0122196. PubMed ID: 25806939
[TBL] [Abstract][Full Text] [Related]
15. Tissue-type plasminogen activator-binding RNA aptamers inhibiting low-density lipoprotein receptor family-mediated internalisation.
Bjerregaard N; Bøtkjær KA; Helsen N; Andreasen PA; Dupont DM
Thromb Haemost; 2015 Jul; 114(1):139-49. PubMed ID: 25855589
[TBL] [Abstract][Full Text] [Related]
16. The fibrinolytic system: A new target for treatment of depression with psychedelics.
Idell RD; Florova G; Komissarov AA; Shetty S; Girard RB; Idell S
Med Hypotheses; 2017 Mar; 100():46-53. PubMed ID: 28236848
[TBL] [Abstract][Full Text] [Related]
17. Retroviral vector-mediated transfer and expression of human tissue plasminogen activator gene in human endothelial and vascular smooth muscle cells.
Ekhterae D; Stanley JC
J Vasc Surg; 1995 Jun; 21(6):953-62. PubMed ID: 7776475
[TBL] [Abstract][Full Text] [Related]
18. Effects of thrombin on steroid-modulated cultured endometrial stromal cell fibrinolytic potential.
Lockwood CJ; Krikun G; Aigner S; Schatz F
J Clin Endocrinol Metab; 1996 Jan; 81(1):107-12. PubMed ID: 8550736
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke.
Zhang Z; Zhang L; Yepes M; Jiang Q; Li Q; Arniego P; Coleman TA; Lawrence DA; Chopp M
Circulation; 2002 Aug; 106(6):740-5. PubMed ID: 12163437
[TBL] [Abstract][Full Text] [Related]
20. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]